ArticlesArchiveAboutEditorial BoardAuthor Guidelines
Call for papersThe 2026 special issue on Climate & Health is open for submissions.Learn more
JCT is an international journal dedicated to the latest advancements in cancer therapy. The goal of this journal is to provide a platform for doctors and academicians all over the world to promote, share, and discuss various new issues and developments in cancer related problems. All manuscripts must be prepared in En…
Hisham Mostafa Kamel Emam, Ehab Mansour Mohammed Moussa, Mohammed Abouelmaged, Maha Ragab Ismail Ibrahim
Background: Radiology plays an essential role in the diagnosis, staging and surveillance of oncology patients. CT is the most sensitive imaging modality in the workup of these patients. Aim of the Study: The aim of this work is to detect the role of MDCT (mul…
Kirsten H. Walen
The objective herein was to connect the ontogeny process of diplochromosomal, amitotic, 4n-skewed division-system, to cytogenetic deficiency lesions in satellite, repetitive DNAs, especially in the chromosomal fragile sites, some 100 distributed over the geno…
Nehal A. Rayan, Amen H. Zaky, Hanan A. Eltyb, Ashraf Zeidan, Asmaa M. Zahran
Background: The neutrophil/lymphocyte ratio (NLR) has been reported to reflect systemic inflammation and independent prognostic significance in different type s of cancer. In present study, we analyzed the association between NLR and clinicopathologic feature…
Panagiotis Apostolou, Ioannis Papasotiriou
The knowledge of the primary origin of tumor is essential in designing an efficient cancer treatment algorithm. Useful diagnostic tools enable determina tion of primary origin of the tumor; however the majority of them require tissue examination. Recent years…
Mauricio Salinas, Mozart Liessi, Patricio Vallejo, Cristian Ibarra
Introduction : Thymus neoplasm is rare tumors and it ha s low mortality. There are scarce publications in Latin-American about this topic. We present a Chilean casuistic. Method : Retrospective cohort of every patient ’ s thymic epithelial tumors diagnosed in…
Panagiotis Parsonidis, Dimitrios-Athanasios Ntanovasilis, Ioannis Papasotiriou
MUC1 is an antigen that is overexpressed on the cell surface of many human breast adenocarcinomas and other types of cancer. The cancer immunity cycle has seven steps, starting with release of cancer cell antigen and following with cancer antigen presentation…
John J. Wille, Mark A. Berhow, Jong Y. Park
Applephenon <sup>®</sup> , a purified extract prepared from green apples, was examined for its cytotoxicity and inhibitory effects on the proliferation of cultures of normal human keratinocytes and several epidermoid cancer cell lines. Our HPLC studies dem…
K. J. Sampath, J. Pridvi, A. Anil, K. Ranjith, L. Swati, S. Nishant
Background: There are very few publications on synchronous presentation of dual malignancies in the literature. Occur re nce of second malignancy in a patient with a known malignant tumor is not uncommon, though synchronous primary malignancies are unusual. C…
Mona Hilmy Alrayes, Reham Hammad, Mohamed Abd Alazim Hussein EL Baddiny, Maha Saleh Madbouly Ibrahim, Mahmoud Hammad
Angiogenesis has an important role in pathophysiology of cancer. FMS-like tyrosine kinase 3 (FLT3) is implicated in hematopoietic malignancies. Their role in childhood acute lymphoblastic leukemia (ALL) pathogenesis needs more enlightenment. Expression of vas…
Alaadin Hussein, Rimoun Boutros, Amani Saber
Background : Breast cancer is still the most common indication for chest wall irradiation, despite the advances in RTH techniques complications still occur, and the time of its occurrence vary and could take few months to many years. ORN usually manifests wit…
No articles in this issue.
JCT is an international journal dedicated to the latest advancements in cancer therapy. The goal of this journal is to provide a platform for doctors and academicians all over the world to promote, share, and discuss various new issues and developments in cancer related problems. All manuscripts must be prepared in En… All articles are open access under a CC BY 4.0 licence, with authors retaining copyright.
Authors submit their manuscript, metadata, and declarations through the portal. There is no submission fee.
The editorial office screens the manuscript for scope, completeness, and formatting before assigning a handling editor.
At least two independent reviewers evaluate the manuscript under single-blind review. Where revisions are required, authors respond point by point.
On acceptance the article processing charge is invoiced and the CC BY 4.0 copyright handover is signed.
The article is copyedited, typeset, and given a DOI, then publishes open access with a permanent link.
Manuscripts must be original and not under consideration elsewhere. Submit in Microsoft Word or LaTeX with figures at 300 dpi minimum. Structure research articles as Abstract, Introduction, Methods, Results, Discussion, and References.
Use the journal's numbered (Vancouver) reference style. Cite sources consecutively in the order they appear, and ensure every reference is complete and retrievable.
Declare all funding sources, conflicts of interest, and ethical approvals (including informed consent and animal-care statements where applicable).